S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
Ad Chaikin Analytics
Buy this oil stock BEFORE the Ukraine war escalates
URGENT: Stocks have been plummeting since Russian’s invasion of Ukraine. The proposed ban of Russian oil could create a historic shock in oil prices and send oil stocks soaring. But do NOT buy Chevron or ExxonMobil. Instead, this small Texas oil stock could make you 100+% if you get in immediately, before the oil crisis escalates.

MarketBeat | Stock Market News and Research Tools

Free Email Newsletter

Sign up to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Latest PodcastContrarian View of the Current Stock Market

In this week's episode of The MarketBeat Podcast, Kate sits down with Brad Conger, deputy chief investment officer at asset management firm Hirtle Callaghan.

Sector Performance

Sector Performance MapSector Performance Map
Ad Wyatt Research Investments
FANG Stocks Are Dead – Your Market Crash Playbook
These 4 unique sectors - destined to be the new dominating forces in the market - and emerging as the next winners are so powerful they could turn every $1,000 into $140,130 within the next 36 months alone. Claim your free report here, to see exactly what they are and why they could replace FAANG stocks for good.

Popular Stocks

CompanyCurrent PricePrice Change
Apple Inc.
Microsoft Co.
Meta Platforms, Inc.
Alphabet Inc.
Amazon.com, Inc.
Tesla, Inc.
Nio Inc -
Alibaba Group Holding Limited
Advanced Micro Devices, Inc.
Canopy Growth Co.
Micron Technology, Inc.
AT&T Inc.
Follow Stocks

Analyst Ratings

United Parcel Service, Inc.
Berenberg BankSet Price Target
FedEx Co.
Berenberg BankSet Price Target
Pfizer Inc.
Berenberg BankSet Price Target
Oyster Point Pharma, Inc.
Piper SandlerLower Price Target
$60.00 ➝ $15.00
Ocular Therapeutix, Inc.
Piper SandlerLower Price Target
$16.00 ➝ $10.00
Neoleukin Therapeutics, Inc.
Piper SandlerLower Price Target
$25.00 ➝ $6.00
Avadel Pharmaceuticals plc
Craig HallumLower Price Target
$20.00 ➝ $15.50
Marker Therapeutics, Inc.
Piper SandlerLower Price Target
$3.50 ➝ $1.50
Leap Therapeutics, Inc.
Piper SandlerLower Price Target
$6.00 ➝ $4.00
Piper SandlerLower Price Target
$80.00 ➝ $35.00
Harpoon Therapeutics, Inc.
Piper SandlerLower Price Target
$14.00 ➝ $9.00
Gracell Biotechnologies Inc.
Piper SandlerLower Price Target
$25.00 ➝ $10.00
See All Analyst Ratings


If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
Ad Vantage Point
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades. We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.